Literature DB >> 6310082

Alpha adrenergic receptor subtypes in human, monkey and dog cerebral arteries.

N Toda.   

Abstract

In helical strips of human and monkey cerebral arteries, norepinephrine produced a greater contraction than that in dog cerebral arteries. In monkey cerebral arteries, phenylephrine and norepinephrine produced a similar magnitude of maximum contractions, although the ED50 value of phenylephrine was approximately 5.6 times greater than that of norepinephrine. Clonidine (up to 10(-5) M) did not produce contractions. Dog cerebral arteries responded to phenylephrine in high concentrations with a greater contraction than that induced by norepinephrine and to clonidine with significant contractions. Contractions induced by norepinephrine of human and monkey cerebral arteries were attenuated by low concentrations of prazosin but were not influenced by yohimbine in concentrations up to 10(-8) M. In contrast, norepinephrine-induced contractions of dog cerebral arteries were attenuated by yohimbine but were unaffected by prazosin. It appears that norepinephrine-induced contractions are mediated by alpha-2 adrenoceptors in dog cerebral arteries and by alpha-1 receptors in human and monkey cerebral arteries as well as monkey and dog mesenteric arteries. The relative unresponsiveness of monkey and dog cerebral arteries to adrenergic nerve stimulation may not be explained by a paucity of alpha adrenoceptors in neuroeffector junction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310082

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Contractile responses of smooth muscle cells differentiated from rat neural stem cells.

Authors:  Kazuhiko Oishi; Yasuhiro Ogawa; Shuji Gamoh; Masaatsu K Uchida
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

2.  Use of α(2)-Agonists in Neuroanesthesia: An Overview.

Authors:  Ehab Farag; Maged Argalious; Daniel I Sessler; Andrea Kurz; Zeyd Y Ebrahim; Armin Schubert
Journal:  Ochsner J       Date:  2011

Review 3.  Perivascular innervation of the cerebral circulation: involvement in the pathophysiology of subarachnoid hemorrhage.

Authors:  H Hara; L Edvinsson
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

4.  Proceedings of the British Pharmacological Society. University of Dundee, 11th-14th September, 1984. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1984-12       Impact factor: 8.739

5.  Effects of the noradrenaline neurotoxin N-2-chloroethyl-N-ethyl-2-bromo-benzylamine hydrochloride (DSP4) on the blood-brain barrier. An experimental study in the mouse using protein tracer and density determination techniques.

Authors:  C Tengvar; C A Pettersson; A K Mohammed; Y Olsson
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Sympathetic denervation and alpha adrenoceptors in dog cerebral arteries.

Authors:  T Tsukahara; T Taniguchi; H Usui; S Miwa; S Shimohama; M Fujiwara; H Handa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

7.  Contractile and relaxant responses of the canine isolated spinal artery to vasoactive substances.

Authors:  K Shirai; Y Kawai; T Ohhashi
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

Review 8.  Cerebral artery signal transduction mechanisms: developmental changes in dynamics and Ca2+ sensitivity.

Authors:  Lawrence D Longo; Ravi Goyal
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

9.  Effect of chlorpromazine on sympathetic neuroeffector transmission in the rabbit isolated pulmonary artery and aorta.

Authors:  O A Nedergaard; J Abrahamsen
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

10.  The major cerebral arteries proximal to the Circle of Willis contribute to cerebrovascular resistance in humans.

Authors:  Esther A H Warnert; Emma C Hart; Judith E Hall; Kevin Murphy; Richard G Wise
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.